K. Kian Ang - Concepedia

Author

K. Kian Ang

The University of Texas MD Anderson Cancer Center

Also Known As

Ang, K. Kian, K Ang, K K Ang, K Kian Ang, K. Ang, K. K. Ang, K. Kian Ang, K.-K. Ang, K.-Kian Ang, K.K Ang

232

Publications

17.3K

Citations

H-Index

165

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Radiation Oncology Associates KU Leuven RTOG Foundation Medical College of Wisconsin

About

K. Kian Ang is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, radiation oncology, and radiation therapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	83	8.6K
2	Health Sciences	29	40	4K
3	Engineering	5	5	364
4	Natural Sciences	1	1	45
5	Allergy	1	1	32

K. Kian Ang

126

Publications

14.9K

Citations

H-Index

Page 1

	Year	Citations
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. K. Kian Ang, Brian Berkey, Xiaoyu Tu, PubMed Advanced HeadTumor BiologyRadiation TherapyEgfr IhcMedicine	2002	1.2K
An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance Lauren A. Byers, Lixia Diao, Jing Wang, Clinical Cancer Research	2012	1.1K
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522 K. Kian Ang, Qiang Zhang, David I. Rosenthal, Journal of Clinical Oncology	2014	821
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system Jerry L. Barker, Adam S. Garden, K. Kian Ang, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyMedical ImagingRadiation TherapyGeometric ChangesCt/linear Accelerator System	2004	740
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225 Nancy Lee, Jonathan Harris, Adam S. Garden, Journal of Clinical Oncology	2009	693
Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial L.J. Peters, Helmuth Goepfert, K. Kian Ang, International Journal of Radiation OncologyBiologyPhysics Neck CancerRadiation TherapyMedicineRadiation DosePostoperative Radiation Therapy	1993	538
Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes Michaela K. Keck, Zhixiang Zuo, Arun Khattri, Clinical Cancer Research	2014	378
Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial Nancy Y. Lee, Qiang Zhang, David G. Pfister, The Lancet Oncology Radiation TherapyRtog 0615MedicineMulti-institutional TrialCancer Treatment	2011	351
Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module David I. Rosenthal, Tito R. Mendoza, Mark S. Chambers, Head & Neck	2007	300
The epidermal growth factor receptor mediates radioresistance Ke Liang, K. Kian Ang, Luka Milas, International Journal of Radiation OncologyBiologyPhysics Signal TransductionCell GrowthMedicineRadiation OncologyCell Signaling	2003	292

Page 1